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Fast chemical neurotransmission is dependent on ionotropic
receptors that are concentrated and immobilized at specific
postsynaptic sites. The mechanisms of receptor clustering and
anchoring in neuronal synapses are poorly understood but
presumably involve molecular linkage of membrane receptor
proteins to the postsynaptic cytoskeleton. Recently the actin-
binding protein a-actinin-2 was shown to bind directly to the
NMDA receptor subunits NR1 and NR2B (Wyszynski et al.,
1997), suggesting that a-actinin-2 may function to attach
NMDA receptors to the actin cytoskeleton. Here we show that
a-actinin-2 is localized specifically in glutamatergic synapses in
cultured hippocampal neurons. By immunogold electron mi-
croscopy, a-actinin-2 is concentrated over the postsynaptic
density (PSD) of numerous asymmetric synapses where it co-
localizes with NR1 immunoreactivity. Thus a-actinin-2 is appro-
priately positioned at the ultrastructural level to function as a
postsynaptic-anchoring protein for NMDA receptors.
a-Actinin-2 is not, however, exclusively found at the PSD;
immunogold labeling was also associated with filaments and
the spine apparatus of dendritic spines and with microtubules
in dendritic shafts. a-Actinin-2 showed marked differential re-
gional expression in rat brain. For instance, the protein is
expressed at much higher levels in dentate gyrus than in area
CA1 of the hippocampus. This differential regional expression
implies that glutamatergic synapses in various parts of the brain
differ with respect to their a-actinin-2 content and thus, poten-
tially, the extent of possible interaction between a-actinin-2 and
the NMDA receptor.
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The NMDA receptor subclass of ionotropic glutamate receptors
has been implicated in the mechanisms of synaptogenesis, synap-
tic plasticity, and excitotoxicity (Constantine-Paton et al., 1990;
Bliss and Collingridge, 1993; Choi, 1995). Like other ionotropic
glutamate receptors, NMDA receptors are concentrated at
postsynaptic sites in glutamatergic synapses. The molecular
mechanisms by which neurotransmitter receptors are clustered
and immobilized at synaptic locations is an active area of research
that promises to reveal new insights into the structural and
functional organization of synapses.
NMDA receptor activity in neurons exhibits mechanosensitiv-
ity (Paoletti and Ascher, 1994) and is dependent on the integrity
of filamentous actin (F-actin) (Rosenmund and Westbrook,
1993), suggesting a functionally important interaction between
NMDA receptors and the postsynaptic actin cytoskeleton. A
number of intracellular proteins may link NMDA receptors to the
cytoskeleton. For instance, the NMDA receptor subunit NR2
binds to the postsynaptic density (PSD)-95 family of putative ion
channel-clustering proteins (Kornau et al., 1995; Niethammer et
al., 1996; Sheng and Kim, 1996), but whether this interaction links
NMDA receptors to the cytoskeleton is unclear. More recently,
a-actinin-2, a member of the spectrin/dystrophin family of actin-
binding proteins, was shown to bind directly to the NMDA
receptor subunits NR1 and NR2B using yeast two-hybrid and in
vitro binding assays (Wyszynski et al., 1997). Given that a-actinins
are actin-binding proteins, we hypothesized that a-actinin-2
might function as a bridging protein between NMDA receptors
and actin at postsynaptic sites. Some circumstantial evidence of
this has been obtained in neurons. At the light microscopic level
in cultured hippocampal neurons, a-actinin-2 shows punctate
colocalization with NMDA receptors at presumptive synaptic
sites (Wyszynski et al., 1997). In addition, a-actinin-2 can be
coimmunoprecipitated in a complex with NMDA receptors from
rat brain (Wyszynski et al., 1997). However, the subcellular local-
ization of a-actinin-2 has not been studied in detail in vivo. The
present study tests this hypothesis by asking whether a-actinin-2
is specifically concentrated in the PSD of glutamatergic synapses
in rat brain and by investigating whether a-actinin-2 colocalizes
with the NMDA receptor at the ultrastructural level. We also
provide here the first report on the developmental and spatial
patterns of a-actinin-2 expression in rat brain. Interestingly,
a-actinin-2 protein exhibits marked differential regional expres-
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sion in rat brain, implying molecular heterogeneity of glutama-
tergic synapses in different parts of the CNS.
MATERIALS AND METHODS
Antibodies, expression constructs, and immunoblotting. Antibodies against
a-actinin-2, NR2B, and PSD-95 have been described (Sheng et al., 1994;
Kim et al., 1995; Wyszynski et al., 1997). Monoclonal anti-Ca 21/
calmodulin-dependent protein kinase II antibody (Chemicon, Temecula,
CA) and anti-NR1 monoclonal antibodies 54.1 (PharMingen, San Diego,
CA) were used for immunoblotting at 1 mg/ml. a-Actinin-2 and
a-actinin-3 expression constructs were prepared by subcloning the full-
length cDNAs for a-actinin-2 or a-actinin-3 into the EcoRI site of the
mammalian expression vector pcDNA3 (Invitrogen, San Diego, CA).
COS-7 cells were transfected using the lipofectamine method (Life
Technologies, Grand Island, NY). Preparation and immunoblotting of
COS-7 cell lysates and brain membranes were performed as described
(Kim et al., 1997). All proteins were visualized using peroxidase-
conjugated secondary antibodies and enhanced chemiluminescence
(ECL) (Amersham, Arlington Heights, IL).
Immunohistochemistry on brain and cultured neurons. Immunohisto-
chemistry on floating 50 mm brain sections was performed as described
(Kim et al., 1996) and was visualized using the Vectastain ABC kit
(Vector Laboratories, Burlingame, CA) and diaminobenzidine (DAB) or
using Cy3- or FITC-conjugated secondary antibodies (Jackson Immu-
noResearch, West Grove, PA). Hippocampal neuronal cultures were
prepared as described (Goslin and Banker, 1991). Primary antibodies
were used at the following concentrations: 4B2 (1 mg/ml), EA-53 (1:
20,000 dilution; Sigma, St Louis, MO), anti-GAD monoclonal antibodies
(1 mg/ml; Boehringer Mannheim, Indianapolis, IN), and anti-GAD-6
monoclonal antibodies (1:2 dilution; Developmental Studies Hybridoma
Bank, University of Iowa, Iowa City, IA); antibodies were visualized
with FITC- and Cy3-conjugated secondary antibodies (2.5 mg/ml; Jack-
son ImmunoResearch) for rat brain sections and with FITC- and Texas
Red-conjugated secondary antibodies (1 mg/ml; Vector Laboratories) for
cultured hippocampal neurons. DAB brain sections and cultured hip-
pocampal neurons were viewed using a Zeiss Axioskop microscope;
fluorescent brain images were recorded using a BioRad MRC 1000
confocal microscope.
Electron microscopy. Male Sprague Dawley rats (200–350 gm) were
anesthetized with pentobarbital (60 mg/kg), briefly flushed with hepa-
rinized saline, and perfused intra-aortically with 0.1 M phosphate buffer,
pH 7.4 (PB), containing 4% freshly depolymerized paraformaldehyde
and either 0.1% glutaraldehyde (for immunoperoxidase labeling) or 2%
paraformaldehyde and 2% glutaraldehyde (for immunogold labeling).
Forty-micrometer-thick frontal sections from brain were cut using a
vibratome and collected in PB.
Pre-embedding immunoperoxidase staining for electron microscopy
was performed using mouse monoclonal a-actinin antibody EA-53. Sec-
tions were pretreated sequentially in 1% sodium borohydride, 50%
ethanol, and 3% hydrogen peroxide in PBS and then blocked in 10%
normal donkey serum. Sections were then incubated sequentially in
EA-53 (diluted 1:50,000–80,000 in PBS containing 0.01% Triton X-100)
overnight, biotinylated donkey anti-mouse serum (1:250 dilution; Jackson
ImmunoResearch) for 2 hr, and ExtraAvidin-peroxidase complex (1:
5,000 dilution; Sigma) for 1 hr. After revealing the peroxidase with
nickel-enhanced diaminobenzidine, sections were osmicated, stained en
bloc in uranyl acetate, and wafer-embedded in Epon-Spurr resin or, for
combining with postembedding immunogold labeling, were processed
without osmium (as described below). To stabilize immunoperoxidase in
the absence of osmium, we incubated sections in platinum chloride (0.5%
in 0.1 M maleate buffer) before embedding.
For postembedding immunogold, sections were embedded as de-
scribed by Phend et al. (1995). Briefly, sections were treated sequentially
over ice in 1% tannic acid in 0.1 M maleate buffer, pH 6.0; 1% uranyl
acetate; 0.5% iridium tetrabromide (Pfaltz and Bauer, Waterbury, CT);
50 and 70% ethanol; 1% phenylenediamine hydrochloride in 70% etha-
nol; and 1% uranyl acetate in 70% ethanol and then dehydrated in 80, 95,
and 100% ethanol. Sections were then immersed in propylene oxide and
infiltrated with Epon-Spurr resin. After overnight infiltration in resin,
sections were sandwiched between strips of Aclar plastic film, flattened
between microscope slides, and polymerized at 60°C for 36 hr. Chips
from layers II–III of S1 cortex were glued onto plastic blocks. Thin
sections (;100 nm) were cut, collected on 300-mesh uncoated nickel
grids, and treated with Quick-Coat (Kiyota Express, Elk Grove, IL) for
improved section adhesion.
For single-labeling, polyclonal a-actinin-2 specific antibodies 4B2
(Wyszynski et al., 1997) were used as described (Phend et al., 1995).
Briefly, grids were washed with Tris-buffered saline containing 0.005%
Tergitol NP-10 (TBS/T) at pH 7.6, incubated at 37°C overnight in TBS/T
containing a 1:8,000–10,000 dilution of 4B2, rinsed in TBS/T at pH 7.6,
transferred to TBS/T at pH 8.2, and incubated in TBS/T containing a
1:20 dilution of secondary gold-conjugated antibody IgG-conjugated to
18 nm gold particles (Jackson ImmunoResearch) or to F(ab) fragments
conjugated to 1.4 nm gold particles (NanoProbes, Stoney Brook, NY).
The 1.4 nm particles were visualized by silver intensification using an HQ
silver kit (NanoProbes).
For the colocalization of a-actinin-2 with the NMDA receptor subunit
NMDAR1 and guanylate kinase-associated protein, either postembed-
ding immunogold on material processed previously with pre-embedding
immunoperoxidase or postembedding immunogold with two antibodies
in adjacent thin sections was performed. Postembedding was performed
as described above using a 1:300 dilution of rabbit polyclonal anti-
NMDAR1 antibodies (Petralia et al., 1994), a 1:300 dilution of affinity-
purified rabbit polyclonal anti-GKAP antibodies (Naisbitt et al., 1997),
and a 1:8000 dilution of the rabbit polyclonal a-actinin-2 specific anti-
bodies 4B2 (Wyszynski et al., 1997). Immunoperoxidase labeling was
performed as described above using a 1:50,000 dilution of mouse mono-
clonal a-actinin specific antibodies (EA-53). After immunocytochemical
processing, grids were air-dried, stained with uranyl acetate and Sato’s
lead, and examined with a JEOL CX200 transmission electron micro-
scope at 80 kV. Virtually no gold particles were seen if the primary
antibody was omitted from the procedure, and no selective labeling of
spines or synaptic structures was seen if preimmune rabbit serum was
substituted for the rabbit polyclonal antisera.
RESULTS
Regional and developmental expression of a-actinin-2
in rat brain
To investigate the expression of a-actinin-2 protein in rat brain,
we generated anti-peptide antibodies (termed 4B2) against a
region of a-actinin-2 that is not conserved in other members of
the a-actinin family of proteins (Wyszynski et al., 1997). To
confirm specificity of the 4B2 antibody, we transiently transfected
COS-7 cells with either a-actinin-2 or a-actinin-3 cDNAs and
fluorescently stained these cells with 4B2 antibodies. 4B2 immu-
noreactivity was observed in COS-7 cells expressing a-actinin-2
but not a-actinin-3 protein (Fig. 1A). As a control, a-actinin-3
expression was confirmed in these cells using anti-peptide anti-
bodies (termed 5B2) that are specific for a-actinin-3 (Fig. 1A).
Similarly, by immunoblotting, 4B2 recognized a-actinin-2 but not
a-actinin-3 protein expressed heterologously in COS-7 cells,
whereas a-actinin-3-specific antibodies showed the reverse spec-
ificity of detection (Fig. 1B). Thus 4B2 can specifically recognize
a-actinin-2 by both immunostaining and immunoblotting. In ad-
dition to 4B2, we took advantage of an independent antibody
raised against a-actinin-2 and -3 (mouse monoclonal EA-53).
Because a-actinin-3 is not expressed in the brain (Fig. 1B) (A. H.
Beggs, unpublished observations), EA-53 antibodies should be
specific for a-actinin-2 in rat brain. On immunoblots of rat brain
membranes, both 4B2 and EA-53 antibodies react with a single
band of ;100 kDa molecular weight, consistent with the known
and predicted size of a-actinin-2 (Beggs et al., 1992) (Fig. 1C).
The fact that the same band is recognized by two independent
antibodies is strong evidence that this 100 kDa band represents
a-actinin-2 protein. 5B2 (a-actinin-3) antibodies failed to detect
any bands in rat brain (Fig. 1B).
By Western blot analysis, a-actinin-2 is found abundantly in
crude synaptosomal membrane fractions from neocortex, hip-
pocampus, and subcortical regions but at low levels in cerebellum
(Fig. 2A). This regional pattern of expression is similar to that of
NR1 and of the a-subunit of Ca21/calmodulin-dependent protein
kinase II (CaMKII), both of which are relatively concentrated in
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forebrain (Fig. 2A). However, in contrast to NR1, a significant
proportion of a-actinin-2 fractionates into the soluble S100 su-
pernatant fraction of brain homogenate (Fig. 2B).
During postnatal development, a-actinin-2 protein is already
detectable in neonatal rat cerebral cortex [age, postnatal day 1
(P1)] but increases during the next 2 weeks to reach high levels of
expression by ;2 weeks after birth (Fig. 2C). The temporal
pattern of a-actinin-2 expression is similar to that of NR1 and
PSD-95 (Fig. 2C), two proteins of the postsynaptic density that
are complexed with a-actinin-2 in vivo (Wyszynski et al., 1997). In
contrast, NR2B (a modulatory NMDA receptor subunit that also
binds directly to a-actinin-2) is present at approximately equal
amounts throughout the postnatal period (Fig. 2C). The increase
in NR1 and PSD-95 expression and the stable expression of
NR2B are in agreement with previous findings (Cho et al., 1992;
Sheng et al., 1994). Thus during the first 2 weeks of postnatal
development, there is a parallel induction in the expression of
a-actinin-2, NR1, and PSD-95 proteins, coincident with an active
period of synaptogenesis in the cortex.
Immunohistochemical localization of a-actinin-2 in
rat brain
The previous study of a-actinin-2 focused on immunolocalization
in cultured hippocampal neurons (Wyszynski et al., 1997). In this
study EA-53 and 4B2 antibodies were used for immunohisto-
chemical localization of a-actinin-2 at the cellular and subcellular
levels in adult rat brain. These independent antibodies gave
essentially identical staining patterns, suggesting that they recog-
nize the true distribution of a-actinin-2 protein. Results using
EA-53 are primarily shown here because this monoclonal anti-
body gave a higher signal-to-noise ratio.
Light microscopic immunocytochemistry reveals that
a-actinin-2 protein is differentially expressed in different regions
of the brain (Fig. 3). Staining is prominent in forebrain structures,
particularly in the striatum, hippocampus, and cortex (Fig. 3A). In
the neocortex, a-actinin-2 staining shows layer specificity, being
strongest in layers II /III and V and weak in layer IV (Fig. 3B). At
the cellular level in cortex, expression of a-actinin-2 is prominent
in pyramidal neurons and in scattered interneurons. Immunore-
activity is prominent in the dendritic processes of pyramidal
neurons and relatively absent from their cell bodies, which stand
out as “holes” against the neuropil staining (see Fig. 3G).
a-Actinin-2 immunoreactivity is strikingly punctate in character
both on pyramidal cell dendrites (Fig. 3C) and in the neuropil of
the neocortex (best demonstrated by immunofluorescence confo-
cal microscopy; Fig. 3G). The pattern of punctate a-actinin-2
staining along apical dendrites suggests localization in dendritic
spines (Fig. 3C). In contrast, scattered interneurons in cerebral
cortex are intensely immunoreactive for a-actinin-2 in their so-
Figure 1. Specificity of a-actinin-2 antibodies (4B2) and a-actinin-3 antibodies (5B2). A, COS-7 cells transfected with a-actinin-2 or a-actinin-3
expression constructs were stained with 4B2, which specifically recognizes a-actinin-2 and not a-actinin-3, or with 5B2, which specifically reacts with
a-actinin-3 and not a-actinin-2. B, Western blot analysis of COS-7 cells transfected with a-actinin-2 or a-actinin-3 (Untrans, untransfected COS-7 cell
control) and of a crude synaptosomal membrane fraction from rat whole brain (10 mg of protein) is shown. 4B2 recognizes a-actinin-2 but not a-actinin-3
protein expressed heterologously in COS-7 cells and a 100 kDa band in brain. 5B2 recognizes a-actinin-3 in COS-7 cells but detects no band in brain.
C, Crude synaptosomal membrane fraction from rat cortex (Ctx Memb; 10 mg of protein) was separated by SDS-PAGE and immunoblotted for a-actinin-2
using EA-53 or 4B2 antibodies. Both antibodies recognize the same 100 kDa band. Positions of molecular weight markers are shown in kilodaltons. a-A-2,
a-Actinin-2; a-A-3, a-actinin-3.
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mata as well as in their dendritic processes (Fig. 3B,E,F). Soma-
todendritic a-actinin-2 immunostaining is also prominent in cells
of the striatum (Fig. 3H). Diencephalic staining is seen in the
thalamic reticular nucleus and lateral hypothalamic nuclei (data
not shown). In the midbrain, staining is prominent in substantia
nigra (Fig. 3A). In the cerebellum, a-actinin-2 immunostaining is
very weak (Fig. 3I), consistent with the low level indicated by
immunoblotting (Fig. 2A). In general, white matter and glial cells
showed no a-actinin-2 labeling.
In the hippocampal formation, a-actinin-2 protein is expressed
throughout the dendritic fields of all regions (Fig. 4A), but stain-
ing is strongest in the molecular layer of dentate gyrus and in area
CA2 (Figs. 3A, 4A). As observed in neocortex, the cell bodies of
hippocampal pyramidal neurons are relatively unstained, whereas
the dendrites of these neurons show dense a-actinin-2 immuno-
reactivity that is remarkably punctate when viewed by high reso-
lution confocal microscopy (Fig. 4C). As seen in the cerebral
cortex, scattered interneurons in the hippocampal region are
heavily labeled for a-actinin-2 (data not shown).
In addition to the punctate dendritic and neuropil staining
found in both neocortex and hippocampus, we reproducibly ob-
served a curious pattern of bright a-actinin-2 immunoreactivity
extending a short distance from the base of pyramidal neurons.
Best seen in layer V pyramidal neurons, it often resembled a short
dashed line, perhaps corresponding to the path of the initial axon
segment of these neurons (see Figs. 3D, 5E). Alternatively, it may
reflect intradendritic staining (A. Rao and A. M. Craig, unpub-
lished observations). A similar bright dashed line pattern of
a-actinin-2 staining could be seen in the hippocampus, inter-
spersed among the cell bodies of the pyramidal and granule cell
layers (Fig. 4B). This pattern of a-actinin-2 staining was noted
with both EA-53 and 4B2 antibodies.
Figure 2. Immunoblot analysis of a-actinin-2 protein expression in rat brain. A, Differential regional expression of a-actinin-2 in rat brain analyzed by
immunoblotting with 4B2 antibodies. Expression of a-actinin-2 (a-A-2) is high in crude synaptosomal membrane fractions from cortex (Ctx),
hippocampus (Hpc), and subcortical regions (Subcx) but very low in cerebellum (Cbl ). Equal amounts of protein (10 mg) were loaded in each lane. The
regional expression patterns of NR1 and the a-subunit of Ca21/calmodulin-dependent protein kinase II (CaMKII) are shown for comparison. B,
Presence of a-actinin-2 in membrane and soluble fractions of rat brain. Lanes were loaded with rat brain fractions as follows: Whole br (total brain
homogenate; 20 mg of protein), Soluble (S100 supernatant fraction of brain homogenate; 30 mg of protein), and Memb (crude synaptosomal membrane
fraction; 10 mg of protein). Equal percentages, rather than equal mass, of membrane and soluble fractions were loaded (the soluble fraction contained
a threefold higher concentration of total protein than did the membrane fraction). Filters were probed with a-actinin-2 4B2 antibodies or with NR1
antibodies. Unlike NR1 protein, a significant amount of a-actinin-2 protein from brain is present in the soluble fraction. C, Expression of a-actinin-2
protein during postnatal cortical development compared with the expression of PSD-95, NR2B, and NR1 proteins. An equal mass (20 mg of protein)
of cortical membranes from various ages were immunoblotted for a-actinin-2. The same immunoblot filter was stripped and reprobed with the PSD-95,
NR2B, and NR1 antibodies. a-Actinin-2 protein expression increases to adult levels during the first 2 weeks of postnatal development, as do PSD-95 and
NR1 expressions. Numbers indicate the postnatal age of rats in days. Positions of molecular weight markers are shown in kilodaltons.
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Selective localization of a-actinin-2 at
glutamatergic synapses
a-Actinin-2 binds directly to NMDA receptors, and its immu-
nocytochemical distribution overlaps with NMDA receptors at
synaptic sites in cultured neurons (Wyszynski et al., 1997). The
highly punctate pattern of a-actinin-2 staining on pyramidal
cell dendrites in rat brain is consistent with its localization at
dendritic spines (Figs. 3C,G, 4C). An important question
raised by these findings is whether a-actinin-2 is present spe-
cifically in synapses containing NMDA receptors (that is,
glutamatergic synapses) or whether it is a general postsynaptic
protein present also in other kinds of synapses such as
GABAergic synapses. This question is best addressed in cul-
tured neurons, in which individual synapses are easier to
resolve than in brain sections.
In primary cultures of hippocampal neurons, a-actinin-2
staining was present in a punctate pattern often corresponding
to dendritic spines (Fig. 5A). The spiny a-actinin-2 clusters
overlapped extensively with clusters of GluR1, an AMPA-type
glutamate receptor subunit (Fig. 5A–C). In contrast,
a-actinin-2 immunoreactivity shows no detectable overlap with
that of glutamic acid decarboxylase (GAD; Fig. 5D), a marker
for GABAergic synapses (the major type of inhibitory syn-
apses in the brain). In some neurons a-actinin-2 is present in
elongated clusters in dendritic shafts, but these shaft clusters
do not correspond to synaptic sites (Rao and Craig, unpub-
lished observations). The absence of immunocolocalization
between a-actinin-2 and GAD is confirmed in vivo by double
labeling of the cerebral cortex (Fig. 5E–G). Thus, a-actinin-2
appears to be concentrated specifically in excitatory glutama-
tergic synapses, consistent with its localization in dendritic
spines.
Figure 3. Immunohistochemical lo-
calization of a-actinin-2 protein in
adult rat brain. A–I, Sagittal (A, B, H,
I ) and coronal (C–G) sections labeled
with a-actinin-2 antibody EA-53 and
visualized via immunoperoxidase
(A–F, H, I ) and immunofluorescence
( G) labeling. A, Low resolution micro-
graph of a rat brain sagittal section
showing a-actinin-2 staining particu-
larly in the striatum (St), cortex (Ctx),
hippocampus (Hpc), and substantia
nigra (Sn). B, Layer-specific expres-
sion in cerebral cortex with predomi-
nent a-actinin-2 staining in layers II /
III and V. Note the a-actinin-2-stained
apical dendrites emanating from layer
V pyramidal neurons and the low lev-
els of staining in layer IV neuropil.
Dark dots in the micrograph represent
intensely labeled cell bodies of a pop-
ulation of interneurons. C, High-
magnification view of a-actinin-2 im-
munoreactive puncta decorating apical
dendrites of layer V pyramidal neu-
rons. D, Cortical layer V showing
a-actinin-2 immunoreactive processes
(arrows) extending a short distance
from the base of pyramidal cell bodies
(arrowheads). E, F, Intense a-actinin-2
staining in scattered cortical interneu-
rons showing diffuse ( E) and punctate
( F) somatodendritic staining patterns.
G, High resolution fluorescence confo-
cal micrograph of cortical layer V
showing punctate nature of a-actinin-2
immunoreactivity in neuropil. Cell
bodies (arrowheads) are relatively
spared of a-actinin-2 staining. H,
Dense a-actinin-2 immunostaining in
cells of the striatum. I, a-Actinin-2
immunostaining in the cerebellum that
is very weak or undetectable. m, Mo-
lecular layer; p, Purkinje cell body lay-
er; g, granular layer; w, white matter.
Scale bars: A, 2.5 mm; B, H, 300 mm; I,
150 mm; C, D, G, 50 mm; E, F, 30 mm.
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Ultrastructural localization of a-actinin-2
The highest level of resolution in immunolocalization is afforded
by immunogold labeling viewed by electron microscopy. Immuno-
gold studies with 4B2 antibodies revealed a-actinin-2 to be mainly
associated with the postsynaptic density and postsynaptic mem-
brane of numerous asymmetric synapses (Fig. 6A–E); symmetric
synapses were labeled weakly if at all (data not shown). In dendritic
spines, labeling was also commonly seen over microfilaments and
the spine apparatus (Fig. 6A–C). In addition, labeling could be seen
adjacent to microtubules in dendritic shafts (Fig. 6F).
Immunoperoxidase staining was qualitatively similar to immu-
nogold labeling, although subsynaptic labeling was more abun-
dant in axospinous synapses, often completely filling the cyto-
plasm of spines, possibly because of diffusion of the reaction
product. By combining pre-embedding immunoperoxidase stain-
ing for a-actinin-2 with postembedding immunogold labeling for
NR1, we observed frequent colocalization (Fig. 7A); this was
most prominent in axospinous synapses. Colocalization at asym-
metric synapses was also apparent between a-actinin-2 and
GKAP, a postsynaptic density protein at excitatory synapses that
interacts directly with the PSD-95/synapse-associated protein
(SAP)-90 family of putative ion channel-clustering proteins (Kim
et al., 1997; Naisbitt et al., 1997) (Fig. 7B–D). The localization of
a-actinin-2 at the PSD, as revealed by immunogold EM, indicates
that a-actinin-2 is appropriately positioned to interact directly
with NMDA receptors.
DISCUSSION
In our initial characterization of a-actinin-2 interactions with
NMDA receptors, we provided evidence with light microscopy
that a-actinin-2 is concentrated in synapses of cultured hip-
pocampal neurons, as well as biochemical evidence that it is a
core component of PSD fractions (Wyszynski et al., 1997). In the
present report, we show that a-actinin-2 is selective for glutama-
tergic synapses. Moreover, using immunogold EM in the intact
brain, we demonstrate that a-actinin-2 is indeed concentrated at
the PSD of asymmetric synapses and that it may be found at
synapses also expressing NR1. These ultrastructural findings in-
dicate that a-actinin-2 is close enough to bind directly to NR1 at
postsynaptic sites. Together with previous data suggesting bio-
chemical association of NR1 and a-actinin-2 (Wyszynski et al.,
1997), these EM results strengthen the idea that a-actinin-2
functions in the synapse as an anchoring protein linking NMDA
receptors to the submembrane actin cytoskeleton.
a-Actinin-2 is not exclusively localized to the PSD, however.
Subsynaptic a-actinin-2 labeling was found associated with mi-
Figure 4. Differential regional expression
of a-actinin-2 protein in the hippocampal
formation. A, DAB histochemistry show-
ing a-actinin-2 immunostaining pattern in
hippocampus. a-Actinin-2 protein is ex-
pressed throughout the dendritic fields of
all regions, but staining is strongest in the
molecular layer of dentate gyrus and in
area CA2. The negative image of the pho-
tomicrograph is shown to improve con-
trast. B, Fluorescence immunocytochem-
istry showing the dashed line pattern of
a-actinin-2 immunostaining seen in hip-
pocampus, interspersed among the cell
bodies of the pyramidal cell layer in CA1.
C, High resolution confocal image of
a-actinin-2 immunostaining showing
bright puncta on the cell bodies and apical
dendrites of CA3 pyramidal cells. Bright
puncta are also present on basal dendrites
of CA3 pyramidal cells (data not shown).
DG, Dentate gyrus; m, molecular layer; p,
stratum pyramidale; sl, stratum lucidum;
so, stratum oriens; sr, stratum radiatum.
Scale bars: A, 500 mm; B, 50 mm; C, 30 mm.
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Figure 5. a-Actinin-2 protein is specifically localized to excitatory synapses and is absent from inhibitory synapses. A–G, Colocalization of a-actinin-2
immunoreactivity with GluR1 in cultured hippocampal neurons (A–C), and noncolocalization of a-actinin-2 and GAD in cultured hippocampal neurons
(D) and in cerebral cortex (E–G). For E–G, the cortical surface is located to the lef t. a-Actinin-2 is visualized by FITC secondary antibody ( green), and
GluR1 and GAD are visualized by Cy3 secondary antibody (red). Composite images (C, D, G) show colocalization of signals as yellow.
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crofilaments and the spine apparatus in dendritic spines. In ad-
dition, a-actinin-2 labeling was detected in dendritic shafts adja-
cent to microtubules and sometimes at sites of membrane contact
between dendrites. Some presynaptic expression of a-actinin-2
can also not be excluded given the ;10–20 nm error inherent in
immunogold localization. However, pre-embedding immunoper-
oxidase labeling also supported a predominantly postsynaptic
concentration of a-actinin-2. Thus a-actinin-2 differs from other
Figure 6. Immunogold labeling (18 nm gold particles) for a-actinin-2 in postsynaptic densities of asymmetric synapses. A, B, Axospinous synapses are
shown; arrowheads point to subsynaptic labeling associated with microfilaments in dendritic spines. C, Arrow denotes dense labeling over the spine apparatus.
D, Arrow denotes prominent gold labeling within the postsynaptic density. E, F, Arrowheads show a-actinin-2 labeling adjacent to microtubules in dendritic
shafts; arrow in E points to labeling over postsynaptic density of an axodendritic synapse; arrow in F points to immunogold over dendrodendritic membrane
apposition. Sp, Spine; r, ribosomal complex; D1, D2, two adjacent dendrites; asterisks mark presynaptic terminals. Scale bars, 250 nm.
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PSD components [such as PSD-95 or GKAP (Naisbitt et al.,
1997)] in showing relatively widespread subcellular distribution
in neurons in addition to its accumulation at the PSD. This is not
surprising given that the a-actinins are actin-binding proteins
found in many cell types and at a variety of cell junctions in
non-neural cells.
The mechanism by which a-actinin-2 is concentrated at syn-
apses remains to be determined. Two known binding partners of
a-actinin-2, NMDA receptors and F-actin, are concentrated in
the PSD and could result in its recruitment to postsynaptic sites.
We found no detectable interaction between a-actinin-2 and the
PSD-95 family of synaptic proteins (M. Wyszynski and M. Sheng,
unpublished observations), despite a C-terminal peptide se-
quence in a-actinin-2 (-ETDL) that resembles known PDZ
domain-binding motifs. We speculate that the a-actinin-2 C ter-
minal may bind to another PDZ-containing protein in synapses.
a-Actinins are known actin-binding molecules, and actin is
concentrated in dendritic spines, constituting a major component
of brain postsynaptic densities (Matus et al., 1982; Hammonds,
1987; Byers et al., 1989). Because of its ability to cross-link actin
filaments, a-actinin-2 could be an important structural compo-
nent of the postsynaptic cytoskeleton. Interestingly, Ca21 inhibits
the actin-binding activity of a-actinin purified from nonmuscle
tissues including brain (Duhaiman and Bamburg, 1984). Calcium
inhibition of actin cross-linking by a-actinin-2 could be a possible
mechanism contributing to activity-dependent remodeling of the
postsynaptic actin cytoskeleton. In contrast to Ca21 effects,
a-actinin binding to F-actin is stimulated by PIP2 (Fukami et al.,
1992), a phospholipid second messenger the synthesis of which is
regulated by RhoA, a small GTPase important in cytoskeletal
regulation. Bidirectional control of a-actinin–actin interactions
via Ca21 and PIP2 signals could contribute to cytoskeletal re-
modeling during activity-dependent structural plasticity of
synapses.
The direct interaction between a-actinin-2 and NMDA recep-
tor subunits represents an attractive mechanism for connecting
NMDA receptors to postsynaptic actin filaments. Such a link has
been implied by electrophysiological studies showing a depen-
dence of NMDA receptor function on the integrity of the actin
cytoskeleton (Rosenmund and Westbrook, 1993). Intriguingly,
NMDA receptor anchoring to actin may be dynamically regu-
lated, because a-actinin-2 binding to NR1 is directly antagonized
by Ca21/calmodulin in vitro (Wyszynski et al., 1997). Thus Ca21
can potentially regulate NMDA receptor attachment to actin via
two mechanisms, displacement of a-actinin-2 from NR1 by cal-
modulin and inhibition of the actin-binding activity of a-actinin.
It is possible that both of these mechanisms could contribute to
Ca21-dependent inactivation of NMDA receptors (Rosenmund
and Westbrook, 1993; Ehlers et al., 1996; Krupp et al., 1996).
Thus a-actinin-2 may play a role in both the localization and
Ca21 modulation of NMDA receptors.
The differential regional expression of a-actinin-2 in rat brain
suggests that glutamatergic synapses in distinct parts of the brain
may differ in terms of their a-actinin-2 content. This finding
emphasizes the heterogeneity of excitatory synapses with respect
to molecular composition. Whether this reflects a functional
heterogeneity of glutamatergic synapses remains to be deter-
mined. a-Actinin-2 exists at very low or undetectable levels in
cerebellar granule cells, suggesting that NMDA receptors in this
region are less likely to interact with a-actinin-2. In the hippocam-
Figure 7. Colocalization of a-actinin-2 with NR1 (A) and GKAP (B–D). A, Postembedding immunogold labeling (18 nm) for NR1 is on synapse stained
also for a-actinin-2 with pre-embedding immunoperoxidase (the star marks postsynaptic electron-dense diaminobenzidine reaction product). B,
Immunogold labeling for GKAP (12 nm gold particles) over postsynaptic density of a-actinin-2-positive profile is shown. C, D, Serial thin sections were
mounted on different grids and processed with silver-intensified immunogold for a-actinin-2 (C) or GKAP (D). One synapse is positive for both antigens
(double arrows); the other is positive for only GKAP (arrowheads on right). Scale bars, 250 nm; C and D are to the same scale.
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pus, NMDA receptor function may be different in CA1 compared
with the dentate gyrus because of differential interactions with
a-actinin-2. In this context, it is intriguing that the CA1 region,
the most sensitive to NMDA receptor-mediated excitotoxicity,
expresses low levels of a-actinin-2.
Outside of the brain, a-actinins are concentrated at the neuro-
muscular junction (Bloch and Hall, 1983), although there is no
evidence that a-actinin interacts with acetylcholine receptors in
this model peripheral synapse. In addition to postsynaptic sites,
a-actinins are known to accumulate at other cell junctions, most
notably at focal adhesions, the sites of contact between cultured
cells and the extracellular matrix (Clark and Brugge, 1995). In
focal adhesions, a-actinin binds through its rod domain directly to
the cytoplasmic tail of b1-integrins (Otey et al., 1990), thus
providing another example of a direct a-actinin interaction with
an integral membrane protein. The linkage of integrins to actin
by a-actinin is thought to play a role in nucleating the integrin-
directed cytoskeletal-signaling complex at focal contacts (Clark
and Brugge, 1995). Focal adhesions and synapses both represent
dynamic sites of membrane specialization where actin filaments
converge, where specific extracellular matrix contacts are made,
and where signaling molecules including tyrosine kinases are
highly concentrated (Clark and Brugge, 1995). The finding that
a-actinin localizes to synaptic junctions reveals that there are
molecular as well as organizational similarities between synapses
and focal contacts.
Evidence converging from several lines of work is beginning to
reveal the complexity of the interactions of NMDA receptors
with cytoskeleton-associated proteins. Because NR2 subunits of
NMDA receptors bind directly to the PSD-95 family of channel-
clustering molecules, the interaction between a-actinin-2 and
NR1 emphasizes that heteromeric membrane receptors may use
multiple mechanisms to interact with the subsynaptic cytoskele-
ton and with postsynaptic-signaling molecules.
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